Inhibition of VEGF receptors causes lung cell apoptosis and emphysema.

Pulmonary emphysema, a significant global health problem, is characterized by a loss of alveolar structures. Because VEGF is a trophic factor required for the survival of endothelial cells and is abundantly expressed in the lung, we hypothesized that chronic blockade of VEGF receptors could induce alveolar cell apoptosis and emphysema. Chronic treatment of rats with the VEGF receptor blocker SU5416 led to enlargement of the air spaces, indicative of emphysema. The VEGF receptor inhibitor SU5416 induced alveolar septal cell apoptosis but did not inhibit lung cell proliferation. Viewed by angiography, SU5416-treated rat lungs showed a pruning of the pulmonary arterial tree, although we observed no lung infiltration by inflammatory cells or fibrosis. SU5416 treatment led to a decrease in lung expression of VEGF receptor 2 (VEGFR-2), phosphorylated VEGFR-2, and Akt-1 in the complex with VEGFR-2. Treatment with the caspase inhibitor Z-Asp-CH(2)-DCB prevented SU5416-induced septal cell apoptosis and emphysema development. These findings suggest that VEGF receptor signaling is required for maintenance of the alveolar structures and, further, that alveolar septal cell apoptosis contributes to the pathogenesis of emphysema.

[1]  R. Stockley,et al.  Animal models of chronic obstructive pulmonary disease , 2001, Thorax.

[2]  D A Lynch,et al.  Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. , 2001, American journal of respiratory and critical care medicine.

[3]  N. Voelkel,et al.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[4]  R. Nicosia,et al.  Regulation of Vascular Growth and Regression by Matrix Metalloproteinases in the Rat Aorta Model of Angiogenesis , 2000, Laboratory Investigation.

[5]  R. Nagai,et al.  Disruption of the klotho gene causes pulmonary emphysema in mice. Defect in maintenance of pulmonary integrity during postnatal life. , 2000, American journal of respiratory cell and molecular biology.

[6]  S. Shapiro,et al.  Animal models for chronic obstructive pulmonary disease: age of klotho and marlboro mice. , 2000, American journal of respiratory cell and molecular biology.

[7]  L. Ellis,et al.  Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. , 1999, Cancer research.

[8]  R. Tuder,et al.  Abnormal lung growth and the development of pulmonary hypertension in the Fawn-Hooded rat. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[9]  Koichiro Yoshino,et al.  Induction of apoptotic cell death in vascular endothelial cells cultured in three-dimensional collagen lattice. , 1999, Experimental cell research.

[10]  M Aguet,et al.  VEGF is required for growth and survival in neonatal mice. , 1999, Development.

[11]  G. Neufeld,et al.  Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  A. Ullrich,et al.  SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. , 1999, Cancer research.

[13]  K. Roth,et al.  In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system , 1998, Cell Death and Differentiation.

[14]  D. Voelker,et al.  Trafficking of newly synthesized surfactant protein A in isolated rat alveolar type II cells. , 1998, American journal of respiratory cell and molecular biology.

[15]  Vishva Dixit,et al.  Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway , 1998, The Journal of Biological Chemistry.

[16]  B. Keyt,et al.  Homologous Up-regulation of KDR/Flk-1 Receptor Expression by Vascular Endothelial Growth Factor in Vitro * , 1998, The Journal of Biological Chemistry.

[17]  V. Dixit,et al.  Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.

[18]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[19]  D. Massaro,et al.  Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats , 1997, Nature Medicine.

[20]  P. Hornsby,et al.  Presence of double-strand breaks with single-base 3' overhangs in cells undergoing apoptosis but not necrosis , 1996, The Journal of cell biology.

[21]  Lieve Moons,et al.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.

[22]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[23]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[24]  N. Voelkel,et al.  Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. , 1995, The Journal of clinical investigation.

[25]  A. Halbower,et al.  Agarose infiltration improves morphology of cryostat sections of lung. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[26]  G. Snider.  Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. , 1989, The American review of respiratory disease.

[27]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[28]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[29]  J. Vance,et al.  Newer Aspects of the Pulmonary Vasculature in Chronic Lung Disease , 1968, Angiology.

[30]  Thurlbeck Wm.  Measurement of pulmonary emphysema. , 1967 .

[31]  B. Møller,et al.  ON THE TREATMENT OF TETANUS. , 2009 .

[32]  S. Eriksson.  Studies in alpha 1-antitrypsin deficiency. , 1965, Acta medica Scandinavica. Supplementum.

[33]  A. Liebow.  Pulmonary emphysema with special reference to vascular changes. , 2015, The American review of respiratory disease.

[34]  L. Cudkowicz,et al.  The Bronchial Arteries in Pulmonary Emphysema * , 1953, Thorax.